Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Philip

Showing results (201-210 of 441) with videos related to

Pageof 45
Sort By:
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|August 4, 2001
[Immunization for children treated for solid tumors: what are the guidelines?]P Marec-Bérard, D Floret, M Schell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
Autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma and CNS involvement: those transplanted with active CNS disease have a poor outcome--a report by the European Bone Marrow Transplant Lymphoma RegistryC D Williams, R Pearce, G Taghipour, et al.
Bulletin Du Cancer|September 24, 2004
Can MIBG scan replace the need for bone marrow assessment at diagnosis and reassessment in stage 4 neuroblastomas?D Frappaz, V Combaret, C Desuzinges, et al.
International Journal of Cancer|December 15, 1986
EBV-negative and -positive Burkitt cell lines variably express receptors for B-cell activation and differentiationM C Favrot, O Maritaz, T Suzuki, et al.
Bulletin Du Cancer|July 27, 1999
[Epidemiology of non-Hodgkin's lymphoma: recent data]C Chassagne-Clément, J Y Blay, I Treilleux, et al.
Blood|October 15, 1995
The C5R protocol: a regimen of high-dose chemotherapy and radiotherapy in primary cerebral non-Hodgkin's lymphoma of patients with no known cause of immunosuppressionJ Y Blay, D Bouhour, C Carrie, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 18, 2000
[Standards, options, and recommendations for radiotherapy of kidney cancer]V Beckendorf, F Bladou, F Farsi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Continuous vincristine infusion as part of a high dose chemoradiotherapy regimen: drug kinetics and toxicityC R Pinkerton, B McDermott, T Philip, et al.
Pediatric Hematology and Oncology|January 1, 1987
Definition of response and remission in children over one year of age with advanced neuroblastoma: proposition for a scoring systemT Philip, L Helson, J L Bernard, et al.
Pediatrie|January 1, 1987
[Methotrexate poisoning: value of exchange transfusion]D Frappaz, E Bouffet, P Biron, et al.
Pageof 45

Showing results (201-210 of 441) with videos related to

Sort By:
Pageof 45
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|August 4, 2001
[Immunization for children treated for solid tumors: what are the guidelines?]P Marec-Bérard, D Floret, M Schell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
Autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma and CNS involvement: those transplanted with active CNS disease have a poor outcome--a report by the European Bone Marrow Transplant Lymphoma RegistryC D Williams, R Pearce, G Taghipour, et al.
Bulletin Du Cancer|September 24, 2004
Can MIBG scan replace the need for bone marrow assessment at diagnosis and reassessment in stage 4 neuroblastomas?D Frappaz, V Combaret, C Desuzinges, et al.
International Journal of Cancer|December 15, 1986
EBV-negative and -positive Burkitt cell lines variably express receptors for B-cell activation and differentiationM C Favrot, O Maritaz, T Suzuki, et al.
Bulletin Du Cancer|July 27, 1999
[Epidemiology of non-Hodgkin's lymphoma: recent data]C Chassagne-Clément, J Y Blay, I Treilleux, et al.
Blood|October 15, 1995
The C5R protocol: a regimen of high-dose chemotherapy and radiotherapy in primary cerebral non-Hodgkin's lymphoma of patients with no known cause of immunosuppressionJ Y Blay, D Bouhour, C Carrie, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 18, 2000
[Standards, options, and recommendations for radiotherapy of kidney cancer]V Beckendorf, F Bladou, F Farsi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Continuous vincristine infusion as part of a high dose chemoradiotherapy regimen: drug kinetics and toxicityC R Pinkerton, B McDermott, T Philip, et al.
Pediatric Hematology and Oncology|January 1, 1987
Definition of response and remission in children over one year of age with advanced neuroblastoma: proposition for a scoring systemT Philip, L Helson, J L Bernard, et al.
Pediatrie|January 1, 1987
[Methotrexate poisoning: value of exchange transfusion]D Frappaz, E Bouffet, P Biron, et al.
Pageof 45